Recent studies suggested that mutations in the gene encoding for cytosolic NADP+ dependant IDH1 (isocitrate dehydrogenase 1) might occur after the formation of a low-grade glioma and direct the progression of the tumor to a glioblastoma [3, 4]. Here, IDH1 is linked to central nervous system cancer.